Research News

Dr. Quyen Chu - LSU Health Shreveport

Dr. Quyen Chu, Professor of Surgery and Chief of the Division of Surgical Oncology at LSU Health Shreveport, is the lead author of the study set for publication in an upcoming issue of Cancer, a journal of the American Cancer Society. 

Read More about LSUHS study finds increase in earlier diagnosis of breast cancer following Medicaid expansion
Feist-Weiller Cancer Center building

SHREVEPORT, La. (KSLA) - Cancer patients from across Northwest Louisiana — who are receiving treatment at MD Anderson Cancer Center in Houston — could soon benefit from new trials closer to home.

Read More about ‘It’s a game changer,’ New clinical trials coming to Feist-Weiller Cancer Center (opens in new window/tab)
Focus Fund and MD Anderson Launch Investment Fund to Support Investigational Cancer Therapies

The Feist-Weiller Cancer Center is excited to be a part of the Cancer Focus Fund to bring the latest new cancer clinical trials to our community," said Dr. Chris Kevil, Vice-Chancellor for Research at LSU Health Shreveport. "We are confident our clinical trial facilities, coupled with expanded patient access to clinical trials across north and central Louisiana in partnership with Ochsner Health, will yield promising results for all citizens of Louisiana.

Read More about Focus Fund and MD Anderson Launch Investment Fund to Support Investigational Cancer Therapies
LSU Health Shreveport Leads Louisiana  in COVID-19 VIRAL GENOME SEQUENCING

The Emerging Viral Threat (EVT) Lab at LSU Health Shreveport has now sequenced a total 651 Louisiana SARS-CoV-2 virus genomes making them the largest contributor to date of genetic data on SARS-CoV-2 in the state. SARS-CoV-2, which is short for ‘Severe Acute Respiratory Syndrome Coronavirus-2,’ is the virus that causes COVID-19, and viral genome sequencing is contributing to a worldwide effort to fight the ongoing pandemic.

Read More about LSU Health Shreveport Leads Louisiana in COVID-19 VIRAL GENOME SEQUENCING
Syringe. Pixabay

LSUHS is expanding enrollment in the Pfizer-sponsored COVID-19 vaccine study for the next two weeks to include individuals ages 16-18 and those older than 85 years of age.  Those interested in participating in this important vaccine trial should sign up as quickly as possible.  

Read More about Pfizer-sponsored COVID-19 Vaccine Study at LSUHS Expands Enrollment Ages
The Louisiana Addiction Research Center  is  Serving our Community and State

Addiction touches the lives of nearly every family. Our mothers, fathers, sons, daughters, and spouses are all at risk of addiction, as are our friends and coworkers. The Louisiana Addiction Research Center is here to serve north Louisiana as well as the entire state, so you and your loved ones are not alone in facing addiction.

Read More about The Louisiana Addiction Research Center is Serving our Community and State
Dr. Rajib Gupta - LSU Health Shreveport

Dr. Rajib Gupta, shares "COVID-19 is an ongoing pandemic which has affected over 12 million people across the globe. Manifestations in different organs systems are being reported regularly. Renal biopsy findings in hospitalized COVID-19 patients presenting solely with acute kidney injury have recently been described in published literature in few case reports. We describe the kidney biopsy findings of two patients who had recent diagnoses of COVID-19 and presented with new-onset nephrotic syndrome."

Read More about Dr. Rajib Gupta research is featured in BMC Nephrology (opens in new window/tab)
Robert Rhoads, PhD

Dr. Robert Rhoads, Professor Emeritus in LSUHS Department of Biochemistry and Molecular Biology shares how work in his lab carried out in collaboration with researchers in Poland and Germany over 30 years is playing a part in the BioNTech/Pfizer COVID-19 vaccine trials.

Read More about Stabilizing messenger RNA may lead to COVID-19 vaccine development